|
Volumn 256, Issue 4, 2009, Pages 554-562
|
Multiple sclerosis patients′ benefit-risk preferences: Serious adverse event risks versus treatment efficacy
|
Author keywords
Benefit risk analysis; Conjoint analysis; Maximum acceptable risk; Multiple sclerosis; Side effect risk
|
Indexed keywords
NATALIZUMAB;
ADVERSE DRUG REACTION;
ARTICLE;
DEATH;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
LEUKEMIA;
LIVER FAILURE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL DECISION MAKING;
MULTIPLE SCLEROSIS;
PATIENT ATTITUDE;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
QUESTIONNAIRE;
RECURRENCE RISK;
RELAPSE;
RISK BENEFIT ANALYSIS;
BAYES THEOREM;
CHOICE BEHAVIOR;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
INTERNET;
MALE;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
MULTIVARIATE ANALYSIS;
NEUROPROTECTIVE AGENTS;
PATIENT ACCEPTANCE OF HEALTH CARE;
QUESTIONNAIRES;
RECURRENCE;
REGRESSION ANALYSIS;
RISK ASSESSMENT;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 65749119370
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-009-0084-2 Document Type: Article |
Times cited : (114)
|
References (38)
|